HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effective tumor treatment by VEGF siRNA complexed with hydrophobic poly(amino acid)-modified polyethylenimine.

Abstract
Two copolymers are designed and synthesised for siRNA delivery based on polyethylenimine by grafting hydrophilic acrylamide segments and hydrophobic poly(γ-benzyl L-glutamate). The amphiphilic PEI-PBLG/siRNA complex demonstrates high gene silencing efficiency in the absence or presence of 10 vol% and 50 vol% sera in vitro. The anti-tumor effects in vivo are evaluated in luciferase-bearing mice expressing CT26 tumors. PEI-PBLG/siVEGF complex provides a higher and more sustained suppressive effect by reducing VEGF mRNA expression in the tumors, leading to higher tumor growth inhibition efficacy. Further studies on the potential use of the PEI-PBLG carrier system in mediating the silencing of genes other than VEGF or in other tumor models are recommended.
AuthorsJie Chen, Huayu Tian, Xuan Dong, Zhaopei Guo, Zixue Jiao, Feifan Li, Arihiro Kano, Atsushi Maruyama, Xuesi Chen
JournalMacromolecular bioscience (Macromol Biosci) Vol. 13 Issue 10 Pg. 1438-46 (Oct 2013) ISSN: 1616-5195 [Electronic] Germany
PMID23873676 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • Polymers
  • RNA, Messenger
  • RNA, Small Interfering
  • Vascular Endothelial Growth Factor A
  • polyethylenimine-poly(gamma-benzylglutamate)
  • Polyglutamic Acid
  • Polyethyleneimine
Topics
  • Animals
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Gene Silencing
  • Genetic Therapy
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Mice
  • Polyethyleneimine (administration & dosage, analogs & derivatives, chemistry)
  • Polyglutamic Acid (administration & dosage, analogs & derivatives, chemistry)
  • Polymers (administration & dosage, chemistry)
  • RNA, Messenger (biosynthesis)
  • RNA, Small Interfering (administration & dosage, chemistry, genetics)
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors, biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: